Colorectal cancer resource library

    Showing 1–20 of 28 results

    Filtered By:
    Poster presentation at ASCO GI
    Blog

    Unmet needs in CRC: Survey results offer hope

    Uncover key survey findings on the unmet psychosocial and physical needs of colorectal cancer patients and survivors, and learn how the Alliance is shaping better care.

    An image of the back of a T-shirt, which has written on it, "Make cancer an election issue."
    Blog

    Be heard this November: The Cancer Promise

    Learn about The Cancer Promise initiative and how political candidates can pledge to support cancer research, prevention, and care policies. Make your voice heard this election.

    The main corridor at the 2025 ASCO Annual Meeting
    Blog

    2025 ASCO update: Six big studies

    The 2025 ASCO Annual Meeting featured several important studies that could change how colorectal cancer is treated, including a pivotal study for BRAF V600E patients.

    Is There a Lynch Syndrome Vaccine on the Way?
    Blog

    Is a Lynch syndrome vaccine on the way?

    Developing a Lynch Syndrome vaccine could change the narrative for patients, reducing screenings and – more importantly – lowering risks for Lynch Syndrome-related cancers.

    USPSTF to Focus on Lynch Syndrome
    Blog

    USPSTF to focus on Lynch syndrome

    Lynch Syndrome is the most common cause of hereditary colorectal cancer, resulting in 4,200 cases per year. It is also more common in younger adults than in other forms of colorectal cancer.

    Blog

    Alliance details results of Clinical Trial Think Tank Summit

    Driven by a commitment to save lives through best practices and innovation in research participation, the group offered collaborative solutions to improve trial design, messaging, access, and navigation, and ultimately, increase participation.

    Trial Shows Improved Survival for Some Metastatic CRC Patients
    Blog

    Trial shows improved survival for some metastatic CRC patients

    Results of a new study announced at the 2023 ASCO Gastrointestinal Cancers Symposium demonstrate that a combination therapy, trifluridine/tipiracil (Lonsurf) plus bevacizumab, has promising activity to increase lifespan in mCRC patients.

    What is Immunoscore?
    Blog

    What is Immunoscore?

    This new technology could refine the prognosis of stage II and some low-risk stage III colon cancer patients and provide doctors with additional information when making decisions about chemotherapy treatment.

    Evan Daniels: Remembering His Father on World Cancer Research Day
    Blog

    Evan Daniels: Remembering his father on World Cancer Research Day

    Evan Daniels is no stranger to the presence of cancer in his life. His father, Robert Daniels, was diagnosed with stage II colon cancer when Evan was just eight years old. Fortunately, Robert’s disease was caught early, and he was able to watch Evan grow.

    support group three people

    Get connected with your allies

    There are many ways to find your community through the Alliance. Try one of our online communities.

    Learn More